Statement re: Further NHS Accreditation
25 April 2023 - 4:00PM
Statement re: Further NHS Accreditation
DXS INTERNATIONAL PLC
(AQSE: DXSP)
Statement Re:
Further NHS
Accreditation
DXS International, the digital clinical decision
support company, is pleased to announce that on Friday 14 April it
received NHS Accreditation for the NHS IM1 Pairing Integration API
which provides read and write access to GP patient data throughout
the UK.
This important achievement alleviates DXS’
dependency on using the existing commercial integrations provided
by the three leading suppliers of primary care patient record
systems in the UK. The development will also significantly enhance
DXS’ ability to deliver its new ExpertCare Hypertension solution to
users such as GPs, nurses and pharmacists throughout the UK,
faster, better and more cost effectively.
This 18-month development initiative included
building the foundation component of a new cloud based Aios
platform which will significantly speed up deployment of various
DXS products, automate user workflows and reduce support
overhead.
David Immelman, DXS CEO, said “This is an
exciting step forward, especially as DXS ExpertCare can help the
NHS achieve its new target in England for GP practices to get
controlled blood pressure up from 60% to 77% of the 8.5 million
hypertensive patients in England which can save thousands of
strokes and heart attacks.”
The Directors of DXS International plc accept
responsibility for this announcement.
Contacts:
| David
Immelman (Chief
Executive)DXS International plc |
01252 719800david@dxs-systems.com |
|
https://www.dxs-systems.co.uk |
|
| Corporate
Advisor |
|
| City &
Merchant David Papworth |
020 7101 7676 |
| Corporate
Broker |
|
| Hybridan
LLPClaire Louise Noyce |
020 3764 2341 |
Notes to Editors
About DXS:
DXS International presents up to date treatment
guidelines and recommendations, from Clinical Commissioning Groups
and other trusted NHS sources, to doctors, nurses and pharmacists
in their workflow and during the patient consultation. This
effective clinical decision support ultimately translates to
improved healthcare outcomes delivered more cost effectively and
which should significantly contribute towards the NHS achieving its
projected efficiency savings.
DXS (AQSE:DXSP)
Historical Stock Chart
From Oct 2024 to Nov 2024
DXS (AQSE:DXSP)
Historical Stock Chart
From Nov 2023 to Nov 2024
